Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-14-011388)

Filing Details

Accession Number:: 0001437749-14-011388
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-17 16:46:53
Reporting Period:: 2014-06-13

Filing Date:: 2014-06-17
Accepted Time:: 2014-06-17 16:46:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181153	S Paul Covington	C/O Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150 Morrisville NC 27560	Senior Vp-Clinical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-06-13	3,228	$104.25	22,523	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (to buy)	$9.11		2020-06-17	45,691	45,691	Direct
Common Stock	Stock Options (to buy)	$15.00		2021-05-09	26,000	26,000	Direct
Common Stock	Stock Options (to buy)	$13.16		2021-10-03	37,944	37,944	Direct
Common Stock	Stock Options (to buy)	$17.80		2022-02-24	10,368	10,368	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-06-17	45,691	45,691	Direct
2021-05-09	26,000	26,000	Direct
2021-10-03	37,944	37,944	Direct
2022-02-24	10,368	10,368	Direct

Footnotes

All options became 100% vested on June 11, 2014 in connection with the Agreement and Plan of Merger dated as of April 27, 2014 by and among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc.